Quality & testing
Endotoxin and Sterility Testing for Research Peptides
What endotoxin is, how LAL and recombinant factor C assays measure it in EU/mg, how sterility testing differs, and why both matter for research materials.
October 30, 2026 · 6 min read · Purity Peptides research team

Two tests on a certificate of analysis are often misunderstood: endotoxin and sterility. They sound similar and both concern bacteria, but they answer different questions. A sterile material can still carry endotoxin, and a material low in endotoxin is not necessarily sterile. This article explains what each test measures, how it works, and why it matters for laboratory research.
What endotoxin is
Endotoxin is lipopolysaccharide (LPS), a large molecule that forms the outer layer of the cell wall of Gram-negative bacteria such as Escherichia coli. It has three parts: a lipid anchor called lipid A, a core oligosaccharide, and a variable O-antigen polysaccharide chain. Lipid A is responsible for most of its biological activity.
Endotoxin is released when bacteria grow and when they die. Three properties make it a persistent quality concern:
- It is extremely potent. Mammalian immune cells detect LPS through the Toll-like receptor 4 (TLR4) complex at picogram-per-millilitre levels.
- It is heat-stable. Ordinary autoclaving does not destroy it; depyrogenation of glassware typically requires dry heat around 250 °C.
- It survives processing. Filtration through a 0.22 µm sterilising filter removes bacteria but not free endotoxin, and lyophilisation does not inactivate it.
Water, buffers, glassware, chromatography resins and handling can all introduce endotoxin into a synthetic peptide, even though the peptide itself is made chemically rather than in bacteria.
Why it matters in research
Because cells respond so strongly to LPS, contaminating endotoxin can produce effects that are wrongly attributed to the peptide under study. Common consequences include:
- Release of inflammatory cytokines such as TNF-α, IL-1β and IL-6 in macrophage and monocyte cultures
- Activation of NF-κB signalling and changes in gene expression
- Altered cell viability or proliferation
- Fever and systemic inflammatory responses in animal models
Any study touching immunology, inflammation, tissue repair or metabolism is particularly vulnerable. A peptide that appears to "activate" immune cells may simply be carrying LPS. For this reason, endotoxin data is worth requesting whenever a model is sensitive to inflammatory signalling.
Measuring endotoxin: the LAL test
The standard bacterial endotoxins test (BET) is based on the blood of the horseshoe crab, Limulus polyphemus. In the 1960s Frederik Bang and Jack Levin showed that horseshoe crab blood clots in the presence of Gram-negative bacteria and endotoxin. The reagent derived from its blood cells is Limulus amebocyte lysate (LAL).
Endotoxin triggers an enzyme cascade in LAL: factor C activates factor B, which activates a proclotting enzyme, which converts coagulogen into a gel. Pharmacopeial methods measure this in three ways.
| Method | Readout | Result type |
|---|---|---|
| Gel-clot | A firm gel forms in the tube | Pass/fail at a set sensitivity, or semi-quantitative by dilution |
| Turbidimetric | Increase in turbidity as gel forms | Quantitative (kinetic or endpoint) |
| Chromogenic | Release of a yellow chromophore from a synthetic substrate | Quantitative (kinetic or endpoint) |
The procedures are described in USP ⟨85⟩ Bacterial Endotoxins Test and the harmonised European Pharmacopoeia chapter 2.6.14.
Recombinant factor C
Recombinant factor C (rFC) assays use a cloned version of the first enzyme in the cascade, which cleaves a fluorogenic substrate when bound to endotoxin. rFC avoids harvesting horseshoe crabs and is not triggered by (1→3)-β-D-glucans, a known source of false positives in some LAL reagents. The European Pharmacopoeia added chapter 2.6.32 for rFC testing, and USP has published a chapter on bacterial endotoxins testing with recombinant reagents. Either approach is acceptable on a research certificate if the method is stated.
Reporting: what EU/mg means
Endotoxin activity is expressed in EU (the endotoxin unit), a measure of biological activity standardised against a reference endotoxin. As a rough guide, one EU corresponds to about 0.1–0.2 ng of reference E. coli endotoxin, though the relationship varies with the source of LPS.
For a peptide, results are normally expressed relative to the mass of material tested, as EU/mg. A result of "< 1 EU/mg" means less than one endotoxin unit was detected per milligram of peptide.
Several technical points affect how much a result can be trusted:
- Inhibition and enhancement. Peptides, salts and extreme pH can interfere with the enzyme cascade. A valid test includes a positive product control (a spike of known endotoxin recovered within 50–200%).
- Dilution. Samples are diluted to overcome interference. The maximum valid dilution depends on the assay sensitivity and the specification.
- Detection limit. A result reported as "less than" a value reflects the assay's sensitivity at the dilution used, not zero endotoxin.
There is no single universal endotoxin limit for research peptides. Pharmacopeial limits for medicines are derived from body weight and exposure, which is not relevant to laboratory use. For research materials, specifications are set by the supplier or by the needs of the experiment; immune-cell studies generally call for the lowest practical levels. Published guidance for preclinical work (Malyala and Singh, 2008) illustrates how investigators can set limits suited to their model.
Sterility testing
Sterility testing asks a different question: are there any viable microorganisms in the product? USP ⟨71⟩ and Ph. Eur. 2.6.1 describe two methods:
- Membrane filtration. The product is dissolved and passed through a 0.45 µm filter, which is then incubated in growth media.
- Direct inoculation. The product is added straight into growth media.
Two media are used: fluid thioglycollate medium for anaerobic and aerobic bacteria, and soybean–casein digest medium for aerobic bacteria and fungi. Incubation lasts at least 14 days. Any growth is a failure.
The sterility test is a limited statistical sample and cannot prove every unit is sterile. Assurance comes mainly from validated aseptic processing or terminal sterilisation. For that reason a sterility claim is meaningful only for material that was actually manufactured and filled to be sterile. Most research peptides are supplied as non-sterile lyophilised powders, and their certificates will not include a sterility result.
Endotoxin vs sterility at a glance
| Question | Endotoxin test | Sterility test |
|---|---|---|
| What is detected | Lipopolysaccharide from Gram-negative bacteria, living or dead | Viable bacteria and fungi |
| Time to result | About 1 hour | At least 14 days |
| Result format | Quantitative, EU/mg | Pass/fail (growth or no growth) |
| Removed by 0.22 µm filtration | No | Yes |
| Typical on research peptide COA | Optional; ask if your model is sensitive | Only for material sold as sterile |
What to look for on a certificate
- The method (gel-clot, kinetic chromogenic, kinetic turbidimetric or rFC) and the chapter followed
- The result in EU/mg, with the specification it was tested against
- Evidence the test was valid, such as spike recovery
- The batch number and test date
For how these results fit alongside purity and identity, see how to read a certificate of analysis, and look up batch documents at /coa.
References
- Levin J, Bang FB. The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp. 1964;115:265–274.
- Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002;71:635–700.
- Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol. 2001;19(8):277–281.
- Malyala P, Singh M. Endotoxin limits in formulations for preclinical research. J Pharm Sci. 2008;97(6):2041–2044.
- United States Pharmacopeia. General Chapter ⟨85⟩ Bacterial Endotoxins Test. USP–NF.
- United States Pharmacopeia. General Chapter ⟨71⟩ Sterility Tests. USP–NF.
- European Pharmacopoeia. 2.6.14 Bacterial Endotoxins; 2.6.32 Test for Bacterial Endotoxins Using Recombinant Factor C; 2.6.1 Sterility.
- US Food and Drug Administration. Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers. 2012.
FOR RESEARCH USE ONLY.Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.


